ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jun 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
July 2026
Nuclear Technology
Fusion Science and Technology
Latest News
Two steps forward for U.K. advanced nuclear
This week, two significant announcements have emerged from the United Kingdom’s advanced reactor sector.
On June 14, Rolls-Royce, the United Kingdom National Nuclear Laboratory, and the Japan Atomic Energy Agency announced that they had signed two trilateral memorandums of cooperation to collaborate on “advanced modular reactor (AMR) technology, specifically high-temperature gas-cooled reactors (HTGR), and the coated particle fuel these reactors will use.”
Separately, on June 16, Bellevue, Wash.–based TerraPower announced that its Natrium reactor design has been formally submitted for U.K. regulatory review. The company also announced the formation of a new subsidiary, TerraPower UK Ltd.
Technical Session|Panel|Sponsored by IRD
Monday, November 13, 2023|3:15–5:00PM EST|Jefferson East
Session Chair:
Erik H. Wilson
Session Organizer:
Alternate Chair:
Lin-Wen Hu
Recent disruptions to the supply of stable and radioactive isotopes have emerged due to geopolitical activities. As well, concerted efforts in the U.S. and internationally over the past few decades have aimed to address growing concerns over isotopes. This panel discussion focuses on efforts to meet demand for isotopes through various methods, such as HALEU reactor-based and accelerator-based production, including plans and progress on development of new production techniques and facilities.
Jon Neuhoff
U.S. Dept. of Energy
Tracy Radel
SHINE Medical Technologies
Christopher Bryan
ORNL